Background: A variety of devices exist for endovascular aneurysm repair (EVAR). Device-specific instructions for use (IFU) detail anatomic constraints to application and deployment of devices and are developed from rigorous bench testing. Nonadherence to IFU occurs frequently to avoid open surgery. The purpose of this study was to determine if IFU violations are associated with increased risk of graft-related adverse events (GRAEs) during follow-up.
Since its introduction in 1991, endovascular aneurysm repair (EVAR) has become the primary repair technique for abdominal aortic aneurysms (AAAs) in most vascular centers. 1, 2 In certain patients, EVAR deployment can be limited by anatomic constraints that compromise graft apposition to the aortic wall or prevent access of the delivery system to the aneurysm. As such, manufacturers outline instructions for use (IFU) for each commercially available stent graft device. Deploying the device within these parameters maximizes device performance and long-term durability. IFU guideline parameters often include infrarenal neck angulation, neck diameter, neck length, and iliac artery diameter and length. IFU parameters are often not adhered to so that the population of patients who are anatomic candidates for EVAR can be expanded. The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
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Copyright According to the literature, IFU nonadherence is high, ranging from 38% to 68.9%. [2] [3] [4] [5] [6] Many studies have found that IFU nonadherence is associated with a lower freedom from reintervention and a lower survival. 2, 3 Nonadherence to proximal aortic neck IFU on its own also seems to have a strong association with negative outcomes, including increased endoleak, reintervention, and late death. 4 Other studies, however, have found that nonadherence is not associated with any difference in outcome. 5, 6 Many of these studies, however, are limited by small sample size, use of primary outcomes with low event rates, lack of long-term outcomes, and use of IFU parameters that are not device specific. The purpose of this study was to determine if devicespecific IFU nonadherence is associated with worse short-term outcome in patients undergoing elective EVAR.
METHODS
Data source and study population. This study was a retrospective cohort design. Consecutive adult patients who underwent elective EVAR for AAA between August 2005 and May 2014 at the McGill University Health Center (Montreal, Quebec) and at the London Health Sciences Centre (London, Ontario) were identified from a clinical database and operative records. Patients were excluded from the study if preoperative computed tomography angiography (CTA) scan or postoperative imaging was not available, the procedure was done to treat symptomatic or ruptured AAA, the patient had prior AAA repair or isolated iliac aneurysm, or iliac branch grafts were used. Indications to proceed with EVAR and device selection to treat AAA were otherwise at the discretion of each vascular surgeon. Clinical characteristics of the patients, anatomic aortic data measured from preoperative CTA, and postoperative follow-up imaging data were recorded. Clinical information of interest was extracted from the electronic medical records, including age, sex, cardiovascular conditions, tobacco use, and antiplatelet and anticoagulant agent use. The type and configuration (bifurcated or aortouni-iliac with femoral-femoral bypass) of the device used were collected from the operative report. Preoperative anatomic measurements included aortic neck diameter and length, infrarenal neck angle, and bilateral common iliac artery diameter and length. These anatomic data were obtained by direct measurement from CTA using axial, sagittal, and coronal views in one hospital center and by CTA reconstruction using Aquarius iNtuition Viewer (TeraRecon, Foster City, Calif) in the second hospital center. Qualified data extractors collected the preoperative and postoperative imaging information in a uniform manner. To define IFU status, preoperative anatomic data were collected and reviewed retrospectively by trained senior vascular fellows, residents, or surgeons who were blinded to the outcome measures.
Follow-up imaging generally consisted of most patients receiving a CT scan at 30 to 90 days after the procedure and at 6 months if endoleak or other concerns were raised by initial CT. CT scan or duplex ultrasound was then yearly performed if no endoleaks or technical concerns were identified on postoperative imaging.
Outcome definition. The primary end point comprised a longitudinal composite outcome of graft-related adverse events (GRAEs). This included any of the following: aortic sac growth (defined as >5 mm of growth during the follow-up period), endoleak (except type II endoleak), any endoleak intervention, device limb occlusion, stent graft migration (caudal displacement >10 mm of proximal graft from position on first postoperative CT scan or any displacement requiring secondary intervention), sac rupture, and aneurysm-related mortality (ARM). Presence of type II endoleak was not included in the outcome as it is usually associated with a benign course and spontaneous resolution; however, if type II endoleak required an intervention, denoting a more malignant course, it was included in the outcome. When endoleaks were identified on CT scan, they were confirmed, if possible, on angiography immediately before reintervention. Patterns of filling on angiography and location of contrast material on CT scan were used to guide endoleak classification. If it was indeterminate, consensus was used for classification. ARM was defined by death within 30 days of the index EVAR or secondary to an aneurysm sac rupture or endoleak intervention at any time during the follow-up period. All outcomes were defined in accordance with the reporting standards for studies of patients with EVAR. 7 IFU adherence was defined as compliance with all IFU criteria as defined by the manufacturer's published criteria and was device specific. The IFU anatomic criteria included were aortic neck diameter and length, infrarenal neck angle, and bilateral common iliac artery diameter and length. If at least one anatomic criterion was not within IFU guidelines, the EVAR placement was Recommendation: This study suggests that IFU violations are associated with graft-related adverse events and adds to the literature that supports adherence to IFU to ensure optimal outcomes. considered nonadherent to IFU. In the setting of aortouni-iliac EVAR configuration, both iliac arteries were required to be outside of IFU to be considered nonadherent.
Statistical analysis. Univariate analysis was used to compare clinical characteristics, clinical information, and rate of GRAEs between the IFU-adherent EVAR group and the IFU-nonadherent EVAR group. Continuous variables were compared using a two-tailed t-test or Wilcoxon rank sum test, and categorical variables were analyzed using a c 2 or Fisher exact test, as appropriate.
The Kaplan-Meier method was used to calculate freedom from GRAEs and to construct survival curves. The log-rank test was used to compare differences between these curves. Cox proportional hazards modeling was used to estimate hazard ratio (HR) between adherence and nonadherence groups. Age and sex were included a priori in the Cox model, as was any variable with a P value of < 0.1 on univariate analysis. Otherwise, statistical significance for all tests was set as P < .05.
Planned analysis was performed on any IFU nonadherence and neck only (diameter and length) IFU nonadherence.
All statistical analysis was performed using SAS software version 9.2 (SAS Institute, Cary, NC).
Approval for conducting this study was obtained from both centers' Institutional Review Boards. The requirement to obtain informed consent was waived under Section 2.1c of the Tri-Council Policy Statement. All personal identifiers were stripped before data analysis to ensure patient anonymity and confidentiality. Outcomes. A total of 289 IFU parameters were not adhered to in 202 patients (43.4%). Iliac artery diameter was the most frequently violated criterion (21.4%), followed by neck diameter (15.2%) and infrarenal neck angulation (14.1%; Table II) .
RESULTS
GRAEs were identified in 59 patients (12.8%) of the cohort. The most common GRAE was nontype II endoleak (8.5%), followed by sac growth (8.1%), endovascular intervention (4.8%), device migration (4.6%), device limb occlusion (1.5%), ARM (0.7%), and sac rupture (0.4%; Survival analysis. The total study period was 10 years with a median follow-up of 1.9 (standard deviation, 1.7) and 2.1 (standard deviation, 1.7) years for patients with and without an IFU violation, respectively. Kaplan-Meier survival curves showed that any IFU nonadherence to at least one parameter had a lower freedom from GRAEs compared with IFU adherence (P ¼ .031; Fig 1) When nonadherence to IFU for proximal aortic neck only was evaluated, it remained significantly associated with a lower freedom from GRAEs (P ¼ .003; Fig 2) . Cox models identified nonadherence to IFU for neck only as an independent predictor of the composite outcome (HR, 2.2; 95% CI, 1.2-4.0), as were age older than 80 years, peripheral vascular disease, and Talent grafts (Table V) .
DISCUSSION
In this multicenter retrospective study, we identified both nonadherence to any IFU and nonadherence to proximal neck IFU to be associated with higher rates of graft-related complications after elective EVAR. This was identified in both unadjusted and adjusted analyses. GRAEs occurred in 16.3% of patients in the group nonadherent to IFU vs 10% in those that fell within the IFU, with the most common adverse events being nontype II endoleaks and ongoing sac enlargement. In patients with neck violations only, neck angle violations were associated with endoleak or endoleak intervention, whereas neck diameter violations were associated with sac growth on univariate analysis. Individual event rates of the components of the composite end point are low, however, requiring caution in interpreting whether absence or presence of causality exists.
IFU nonadherence in our study was 43.8%, which is similar to the published literature (38%-68.9%). [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] The impact of IFU nonadherence on outcomes remains controversial, with conflicting results between studies. In a widely cited study, Schanzer et al reviewed postoperative imaging from a third-party repository and identified a 41% rate of sac growth after EVAR among patients who had deployments outside IFU, although this study was criticized for its use of a selected population of patients, limited procedural data, and generic IFU. 5 Abbruzzese et al, in a study of >500 EVAR patients, found a higher rate of GRAEs in a group of patients treated outside the IFU, particularly with higher rates of limb thrombosis (2.3% vs 0.3%). 2 In a similarly sized study, AbuRahma et al found IFU nonadherence to be associated with higher rates of early and late type IA endoleaks (7% vs 18%), early reinterventions (18% vs 24%), and worse long-term survival. 8 In a systematic review of 16 observational studies, EVAR with hostile neck anatomy falling outside the IFU was associated with a higher risk of reinterventions and type IA endoleaks. 9 In contrast, Lee et al, in a single-center review of 218 patients, found non-IFU neck anatomy to have no impact on endoleaks, sac regression, migration, and reinterventions after EVAR. 10 This may partially be explained by the high rates of aortic cuff use in the non-IFU group (13.7%) and the high rate of midterm reinterventions in both the IFU and non-IFU groups (>16%). Similarly, Walker et al, in a multicenter registry of 489 patients with a median follow-up of 3 years, found that IFU nonadherence had no impact on mortality, ARM, sac growth, reinterventions, or endoleaks. This study did suffer from some selection bias as only 28% of the potentially eligible patients had anatomic data available to the investigators. 11 Beckerman et al, in a recent study of 566 patients, found that only 31% of grafts were deployed within the IFU and that IFU adherence had no impact on early or late outcomes, including mortality, reinterventions, and endoleaks. 12 The conflicting results are likely a result of several limitations in the published literature. First, most of these studies have looked at isolated clinical end points with low event rates rather than composite end points, decreasing the likelihood of attaining statistical significance. We chose to look at GRAEs, a composite end point encompassing various outcomes that are all influenced by challenging anatomy, increasing our power to detect differences between the IFU and non-IFU groups. Second, most studies suffer from short followup, with many limited to 3 years or less. This is particularly relevant as the recent publication of the long-term results of the EVAR 1 trial have shown worse mortality in the EVAR group beyond 8 years, primarily the result of increased rates of secondary aneurysm sac rupture. 13 All patients in the EVAR 1 trial had anatomy considered appropriate for EVAR, and one would assume that the effects of nonadherence to IFU would only increase these risks of long-term EVAR failure. Since its inception, endovascular grafts used to perform EVAR have undergone multiple design modifications to overcome constraints imposed by complex anatomy. Lower profile delivery systems are now available as small as 14F, providing EVAR access vessel suitability for 90% of men and 70% of women. 14,15 Uncovered stents, suprarenal fixation, radial force from self-expanding stents, and increased columnar strength have been some additions commonly found in modern grafts that maximize neck apposition and decrease migration. More recently, sealing rings filled with radiopaque polymer have allowed reliable sealing of short-neck ($7 mm) aneurysms; however, the long-term results of these devices are still unknown. The chimney and snorkel adjuncts offer an alternative to complex neck anatomy that falls outside the IFU for standard available endografts but are associated with high rates of gutter leaks 16 that are exceedingly complex to treat. Caution should be used before considering these procedures because advanced endovascular skills are required to perform them safely, and both the endografts and the covered and uncovered stents employed to create the snorkel or chimneys are being deployed outside their respective IFUs. There are some favorable published short-term outcome data from experienced centers related to these procedures, although the durability of chimneys and snorkels is currently not known. More complex solutions, such as custom branched EVAR and fenestrated EVAR, remain promising solutions to complex neck aneurysms. As they become more accessible to U.S. centers, many are touting these custom grafts as the solution to complex anatomy. However, the significantly elevated cost of these grafts, the 4-to 6-week custom order waiting period, the requirement of advanced endovascular skills, the considerable procedural times, and the potential inadvertent branch vessel occlusion associated with custom grafts create impracticality and make them less appropriate for small-volume centers. Such custom grafts have been available in Canada for approximately 15 years and are commonly used in most academic centers. Through the period of our study, custom grafts were available to all surgeons as an alternative for complex anatomy cases at the two study centers, one of which also offers a complex aortic endovascular program and fellowship. Yet, a relatively high rate of IFU nonadherence was still found in this series that is consistent with the published literature. It is likely that because of the impracticality of applying custom techniques to a high rate of AAAs that are outside of IFU parameters and for the other listed issues, surgeons continue to elect to push the limits of device capabilities for standard endografts. It is our belief that this will also hold true in the U.S. market and fail to solve the complex anatomy issue. Finally, let us not forget how AAA repair began; open repair remains a viable and reliable solution for many of these cases.
Our study has several limitations. First, it is a retrospective design that introduces an inherent bias, which may not be controlled for in our analysis. Other sources of bias included patient and device selection, which was under the individual surgeon's discretion and not determined by a protocol. Although this would represent a real-world experience, certain devices may have specifically been chosen for patients who were outside the IFU guidelines. Many patients in our study may have had preintervention or follow-up CT scans done at sites outside the study centers. These scans may not have been stored or are not currently accessible to the study center. This has contributed to a high exclusion rate and a median follow-up of approximately 2 years despite a 10-year study period. A greater proportion of EVARs were performed in the latter half of the study period (>60%), which would also contribute to a shorter median follow-up than expected. Last, different radiographic modalities were used for measurement between the two centers. Although this does control for some bias in that the preoperative and postoperative measurements are done with the same modality, it may introduce differences between centers.
CONCLUSIONS
Our study confirms that performing EVAR outside device-specific IFU is common in clinical practice. Our study also identified that any IFU violation was significantly associated with an increased risk of GRAEs over time. Caution should be considered in offering EVAR repair to patients whose anatomy is not compliant with IFU parameters. Widespread aggressive application of EVAR in nonadherent IFU patients should be limited, and other endovascular and open options must be considered. In some comorbid patients, this may still remain the lowest risk option for AAA repair. Other patients may be willing to accept the higher risk of GRAEs to avoid a laparotomy or complex open repair. In these instances, a patient must be properly advised and consented for these risks. At the very least, if patients are treated using standard EVAR devices outside IFU, these patients warrant close follow-up imaging. Further device development and creative solutions in EVAR technology may someday yield a universal device for complex anatomy, but for now, we must use all the options available to provide the best care for each individual patient. 
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